COEP Stock Summary and Trading Ideas (Coeptis Therapeutics Holdings | NASDAQ:COEP)

Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.

Coeptis Therapeutics Holdings trades on the NASDAQ stock market under the symbol COEP.

As of April 2, 2026, COEP stock price climbed to $11.98 with 17,112 million shares trading.

COEP has a beta of -0.12, meaning it tends to be less sensitive to market movements. COEP has a correlation of 0.00 to the broad based SPY ETF.

COEP has a market cap of $74.55 million. This is considered a Micro Cap stock.

In the last 3 years, COEP traded as high as $43.80 and as low as $2.31.

The top ETF exchange traded funds that COEP belongs to (by Net Assets): VTI, VXF.

COEP has outperformed the market in the last year with a price return of +26.4% while the SPY ETF gained +17.5%. However, in the short term, COEP had mixed performance relative to the market. It has underperformed in the last 3 months, returning -18.2% vs -3.7% return in SPY. But in the last 2 weeks, COEP shares have fared better than the market returning +6.0% compared to SPY -0.1%.

COEP support price is $10.61 and resistance is $11.96 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that COEP shares will trade within this expected range on the day.